» Authors » Daniela Guarnieri

Daniela Guarnieri

Explore the profile of Daniela Guarnieri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 737
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Trerotola A, Gravina G, Vykhovanets V, Blal N, Guarnieri D, Maranzana A, et al.
J Inorg Biochem . 2025 Mar; 267:112875. PMID: 40043349
In this contribution, the synthesis and the reactivity with HS of a family of half-salen Zn complexes are reported. We provide evidence that HS binds the zinc center of all...
2.
Blal N, Guarnieri D
Methods Mol Biol . 2023 Dec; 2748:85-98. PMID: 38070109
Immunotherapy is considered a powerful clinical strategy aiming to boost the immune system to fight cancer. In this context, nanomaterials (NMs) are uniquely suited to improve the development and the...
3.
Muscetti O, Blal N, Mollo V, Netti P, Guarnieri D
Nanomaterials (Basel) . 2023 Jul; 13(13). PMID: 37446515
To improve the efficacy of nanoparticles (NPs) and boost their theragnostic potential for brain diseases, it is key to understand the mechanisms controlling blood-brain barrier (BBB) crossing. Here, the capability...
4.
Strianese M, Ferrara G, Vykhovanets V, Blal N, Guarnieri D, Landi A, et al.
Sensors (Basel) . 2023 Feb; 23(4). PMID: 36850620
In this contribution we report the synthesis and full characterization, via a combination of different spectroscopies (e.g., H NMR, UV-vis, fluorescence, MALDI), of a new family of fluorescent zinc complexes...
5.
Migliaccio V, Blal N, De Girolamo M, Mastronardi V, Catalano F, Di Gregorio I, et al.
ACS Appl Mater Interfaces . 2023 Jan; 15(3):3882-3893. PMID: 36629473
The catalytic and antioxidant properties of platinum nanoparticles (PtNPs) make them promising candidates for several applications in nanomedicine. However, an open issue, still shared among most nanomaterials, is the understanding...
6.
Vestuto V, Amodio G, Pepe G, Basilicata M, Belvedere R, Napolitano E, et al.
Biomedicines . 2022 Aug; 10(8). PMID: 36009556
Parkinson's disease (PD) represents one of the most common neurodegenerative disorders, characterized by a dopamine (DA) deficiency in striatal synapses and misfolded toxic α-synuclein aggregates with concomitant cytotoxicity. In this...
7.
Strianese M, Vykhovanets V, Blal N, Guarnieri D, Landi A, Lamberti M, et al.
Sensors (Basel) . 2022 May; 22(9). PMID: 35590862
In this work, the authors explored the interaction of a suite of fluorescent zinc complexes with HS. The authors provide evidence that HS binds the zinc center of all the...
8.
Sitia L, Catelani T, Guarnieri D, Pompa P
ACS Appl Bio Mater . 2022 Jan; 2(8):3279-3289. PMID: 35030770
Predicting the therapeutic efficacy of a nanocarrier, in a rapid and cost-effective way, is pivotal for the drug delivery to the central nervous system (CNS). In this context, in vitro...
9.
Strianese M, Brenna S, Attilio Ardizzoia G, Guarnieri D, Lamberti M, DAuria I, et al.
Dalton Trans . 2021 Nov; 50(46):17075-17085. PMID: 34779449
In this work we explore the interaction of HS with a family of fluorescent zinc complexes. In particular we selected a family of complexes with N,O-bidentate ligands aiming at assessing...
10.
Carnovale C, Guarnieri D, Di Cristo L, De Angelis I, Veronesi G, Scarpellini A, et al.
Nanomaterials (Basel) . 2021 Jul; 11(6). PMID: 34204296
Grouping approaches of nanomaterials have the potential to facilitate high throughput and cost effective nanomaterial screening. However, an effective grouping of nanomaterials hinges on the application of suitable physicochemical descriptors...